Characterization of a cancer/testis (CT) antigen gene family capable of eliciting humoral response in cancer patients (original) (raw)
Expression of multiple cancer/testis (CT) antigens in breast cancer and melanoma: Basis for polyvalent CT vaccine strategies
Ugur Sahin
International Journal of Cancer, 1998
View PDFchevron_right
Antibodies against the cancer-testis antigen CTSP-1 are frequently found in prostate cancer patients and are an independent prognostic factor for biochemical-recurrence
Fabiana Bettoni
International Journal of Cancer, 2008
View PDFchevron_right
Cancer-testis antigens: An update on their roles in cancer immunotherapy
Sepideh Dashti
Human Antibodies, 2019
View PDFchevron_right
Cancer testis antigens
Archana Verma
OncoImmunology, 2012
View PDFchevron_right
Cancer testis antigens: A new paradigm for cancer therapy
Nirmala Jagadish
2012
View PDFchevron_right
Serological identification of human tumor antigens
Ugur Sahin
Current Opinion in Immunology, 1997
View PDFchevron_right
Oncogenic cancer/testis antigens: prime candidates for immunotherapy
Henrik Ditzel
Oncotarget, 2015
View PDFchevron_right
Identification of a novel prostate cancer-associated tumor antigen
Alistair Rogers
The Prostate, 2007
View PDFchevron_right
Cancer/testis antigens for therapeutic use
Stephanie McArdle
Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 2009
View PDFchevron_right
Cancer/testis tumour-associated antigens: immunohistochemical detection with monoclonal antibodies
Antonio Juretić
The Lancet Oncology, 2003
View PDFchevron_right
Cancer-testis antigens: potential targets for cancer immunotherapy. Arch Iran Med
Soudeh Ghafouri-Fard
Archives of Iranian medicine
View PDFchevron_right
Directions in the immune targeting of cancer: Lessons learned from the cancer-testis Ag NY-ESO-1
Weisan Chen
Immunology and Cell Biology, 2006
View PDFchevron_right
New strategy for the identification of squamous carcinoma antigens that induce therapeutic immune responses in tumor-bearing mice
I. O-sullivan
Cancer Gene Therapy, 2007
View PDFchevron_right
Enhancement of antitumour immunity by a novel chemotactic antigen DNA vaccine encoding chemokines and multiepitopes of prostate-tumour-associated antigens
Wenbo Ma
Immunology, 2006
View PDFchevron_right
Elicitation of T Cell Responses to Histologically Unrelated Tumors by Immunization with the Novel Cancer-Testis Antigen, Brother of the Regulator of Imprinted Sites
Dmitri Loukinov
The Journal of Immunology, 2007
View PDFchevron_right
MAGE-C1/CT7 is the dominant cancer-testis antigen targeted by humoral immune responses in patients with multiple myeloma
Alexander Knuth
Leukemia, 2008
View PDFchevron_right
Cancer-testis antigens: potential targets for cancer immunotherapy
Soudeh Ghafouri-Fard
Archives of Iranian medicine, 2009
View PDFchevron_right
The shared tumor‐specific antigen encoded by mouse gene P1A is a target not only for cytolytic T lymphocytes but also for tumor rejection
Benoit Van den Eynde, Janine Bilsborough
European journal of …, 1998
View PDFchevron_right
Identification of tumor antigens as potential target antigens for immunotherapy by serological expression cloning
Dirk Jäger
Cancer Immunology, Immunotherapy, 2004
View PDFchevron_right
Inducible expression of cancer-testis antigens in human prostate cancer
Emmanuel Berchmans
Oncotarget, 2016
View PDFchevron_right
Identification and Validation of Targets for Cancer Immunotherapy: From the Bench-to-Bedside
Dagmar Sigurdardottir
Novel Gene Therapy Approaches, 2013
View PDFchevron_right
Expression of cancer testis antigens in human BRCA-associated breast cancers: potential targets for immunoprevention
Sylvia Adams
Cancer Immunology Immunotherapy, 2011
View PDFchevron_right
Cancer vaccines and immunotherapy
Said Dermime
British medical bulletin, 2002
View PDFchevron_right
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
Lawrence Fong
Proceedings of the National Academy of Sciences, 2008
View PDFchevron_right
Specific antitumor immune response induced by a novel DNA vaccine composed of multiple CTL and T helper cell epitopes of prostate cancer associated antigens
Wenbo Ma
Immunology Letters, 2005
View PDFchevron_right
Cellular and humoral immune responses against cancer: implications for cancer vaccines
Mauricio Jose Rodrigues
Current Opinion in Immunology, 1991
View PDFchevron_right
Expression of cancer/testis antigens in prostate cancer is associated with disease progression
Prakash Kulkarni
The Prostate, 2010
View PDFchevron_right
Tumor-associated antigens and development of immunotherapeutics strategies
valeriy filonenko
Biopolymers and Cell, 2005
View PDFchevron_right
Multiepitope CD8+ T cell response to a NY-ESO-1 peptide vaccine results in imprecise tumor targeting
charles hesdorffer
Journal of Clinical Investigation, 2002
View PDFchevron_right
Characterization of human prostate and breast cancer cell lines for experimental T cell-based immunotherapy
Magnus Essand
The Prostate, 2007
View PDFchevron_right
Frequent expression of the novel cancer testis antigen MAGE-C2/CT-10 in hepatocellular carcinoma
Pierre-alain Clavien
International Journal of Cancer, 2009
View PDFchevron_right
Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets
Julie Decock
Frontiers in Oncology
View PDFchevron_right